ArticleBlood advances2023

Orally bioavailable BTK PROTAC active against wild-type and C481 mutant BTKs in human lymphoma CDX mouse models.

Ye Seul Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.